Market revenue in 2023 | USD 29.3 million |
Market revenue in 2030 | USD 43.2 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.72% in 2023. Horizon Databook has segmented the Argentina intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina is one of the key emerging markets worldwide, however, the country struggles to maintain credibility with investors with very high inflation rates. Argentina has a high burden of chronic disease, with diabetes on the top, followed by cancer, according to WHO.
The high prevalence of diabetes has burdened the national health care budget and the economy in the form of loss of productivity. The rise in aging population, unhealthy lifestyles adopted by citizens, and increasing prevalence of diseases such as cancer & diabetes requiring exclusive dosage & delivery of medications are likely to propel the intravenous infusion pumps market in the country.
The developing healthcare infrastructure and lack of favorable reimbursement policies are likely to impede market growth over the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Argentina intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account